Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan

Clinical trial NCT02808403 · COMPLETED

Trial details

NCT number: NCT02808403
Sponsor: Amgen
Status: COMPLETED
Study type: OBSERVATIONAL

Hypercholesterolemia Familial Hypercholesterolemia

Start date: 2016-06-24
Primary completion: 2022-10-31
Enrollment: 6000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.